Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Attendees who have favorited this...

  • Tracey Fox
    Executive Director, Regulatory Affairs
    Olympus Corporation
  • Kristi Frisch
    Regulatory Affairs Specialist, Principal
    Arthrex
  • Lisa Gault
    Director, Regulatory Operations
    Melinta Therapeutics Inc.
  • Daphne King
    Associate Director, Regulatory Affairs, CMC/Medical Devices
    BioMarin Pharmaceutical Inc.
  • Leyna Mulholland
    Director, Global Regulatory Affairs
    Jazz Pharmaceuticals - ENTERPRISE
  • Diana Najarian
    Senior Manager, Nonclinical Writing
    Alnylam Pharmaceuticals
  • Kim Parker Howard
    Owner
    KP Howard Consulting
  • Cassandra San Jose
    Director, Global Regulatory Submission Planning
    Biogen
  • Despina Vasiliou
    Manager, Regulatory Affairs
    Innovaderm Research Inc.